Bifogade filer
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Bioteknik |
Bio-Works Technologies AB has received an order for WorkBeads 40S valued at SEK 2.5 million from a returning customer in Sweden.
The customer is a global contract development and manufacturing organization (CDMO) focused on peptide- and oligonucleotide-based therapies.
"The order from a returning global CDMO confirms our strong position in the purification of peptide- and oligonucleotide-based pharmaceuticals. It is a clear sign that Bio-Works delivers solutions that meet the highest standards of quality and performance," says Lone Carlbom, CEO of Bio-Works.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on "Innehållet inom klamrarna kommer ersättas med rätt tid och datum vid utskickstillfället">15-05-2025 15:02 CET.